A detailed history of Pro Share Advisors LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 17,696 shares of VERV stock, worth $92,904. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,696
Previous 13,512 30.97%
Holding current value
$92,904
Previous $188,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$10.81 - $17.96 $45,229 - $75,144
4,184 Added 30.97%
17,696 $235,000
Q4 2023

Feb 14, 2024

BUY
$8.84 - $18.7 $24,354 - $51,518
2,755 Added 25.61%
13,512 $188,000
Q3 2023

Nov 13, 2023

BUY
$11.42 - $20.82 $1,735 - $3,164
152 Added 1.43%
10,757 $142,000
Q2 2023

Aug 10, 2023

BUY
$13.34 - $19.9 $141,470 - $211,039
10,605 New
10,605 $198,000
Q4 2022

Feb 02, 2023

BUY
$17.85 - $40.7 $18,796 - $42,857
1,053 Added 10.47%
11,112 $215,000
Q3 2022

Nov 04, 2022

BUY
$15.63 - $41.49 $157,222 - $417,347
10,059 New
10,059 $345,000
Q2 2022

Aug 01, 2022

SELL
$11.14 - $23.17 $131,641 - $273,799
-11,817 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$20.92 - $39.36 $33,367 - $62,779
1,595 Added 15.6%
11,817 $270,000
Q4 2021

Feb 08, 2022

BUY
$31.94 - $54.82 $326,490 - $560,370
10,222 New
10,222 $377,000

Others Institutions Holding VERV

About Verve Therapeutics, Inc.


  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $315M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.